COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Diabetes, coronary heart disease increase risk of long COVID, large new study confirms

Reviewing data from more than 800,000 patients, researchers also emphasized that patients vaccinated against COVID-19 are less likely to experience long-lasting symptoms.

Thumbnail

Long-term fasting improves heart-related outcomes for at-risk COVID-19 patients

New research presented at the American College of Cardiology’s annual meeting has shown that long-term intermittent fasting improved outcomes for individuals with COVID-19 who also have a history of heart disease.

Valentin Fuster, MD, PhD, director of Mount Sinai Heart and general director of the Spanish National Center for Cardiovascular Research

High dosage of blood thinners lowers 30-day morbidity for hospitalized COVID-19 patients

For patients who were hospitalized, but not yet in the ICU, those randomly assigned a higher-dose of anticoagulants had lower 30-day mortality risk than those on a lower dose. 

COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

Heart inflammation remains 2 months later in some patients with COVID-19 vaccine-related myocarditis

A team of cardiologists and radiologists collaborated on the study, using advanced imaging to take a closer look at the long-term impact of vaccination. 

An attendee tries out a hands-on TEE simulator in a packed GE Healthcare booth at ACC.23. Photo by Dave Fornell

ACC.23 emerges as a return to normalcy for the cardiology community

Attendance was higher for the conference in 2023 than in 2019, the last year before the COVID-19 pandemic. 

Confirmed: Long COVID more than doubles a person’s risk of heart issues

According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications. 

Yes, COVID-19 increases a person’s diabetes risk—but vaccination may help

Patients who are vaccinated at the time of their COVID-19 diagnosis appear to face a lower risk of new-onset type 2 diabetes than patients who are not vaccinated. 

Heart palpitations, chest pain among the long-lasting side effects of COVID-19, new research confirms

“Before we examined the data, I thought we would find an ample amount of the symptoms to be specifically associated with long COVID, but that wasn’t the case," one researcher said. 

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.